Observational Studies

Below is a list of our observational studies. Please reach out to [email protected] for more information on the studies or if you have any questions about enrolling in research!


Active/Upcoming Studies


Amyotrophic Lateral Sclerosis (ALS) 

ALS-CMOP

Enrolling

Full Study Name: Characterizing Microbial Markers Predictive for ALS Onset and Progression (ALS-CMOP)

Purpose:  This study is evaluating whether certain microbial species, genes, and metabolites from the gut microbiome may contribute to an increased risk and more rapid progression of ALS. Patients enrolled in this study will also be simultaneously enrolled in MOVR. 

Participants: Patients with ALS, their spouse (or other adult that shares a living space with the patient), and georgraphically-matched healhty volunteers will be able to join this study. 

Study Length: The study includes 2 visits. The first will be a zoom or phone call to go over the consent form and answer any questions you may have regarding the study. If you agree to participate, we will send you a stool sample collection kit to your home. The second visit will be a zoom or phone call during which we will ask you questions regarding your lifestyle and diet, and you will collect a stool sample the same day. You will not receive any new or experimental treatments as part of the study. While active participation will take about 2 hours of your time, we will continue to access your medical records to track your progression indefinitely.

Sponsor: Department of Defense

Compensation: In return for your time and effort, you will be provided a total of $50 in Amazon gift cards.
You will receive a $25 Amazon gift card for completing the lifestyle questionnaire with a study team member and you will receive a $25 Amazon gift card once we receive your stool sample.

Principal Investigator: Catherine Lomen-Hoerth, MD, PhD

I'm Interested

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

HYbISCUE (TAK-771-508)

Active - Enrolling 

Full Study Name: A Global Real-World Study to Assess HyQvia Use and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Switching to HyQvia

Purpose:  The purpose of this research is to collect real world information regarding people with Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are currently or plan to start taking HyQvia®.  

Participants: Adult participants with CIDP who have had a stable disease course for at least 12 weeks. Participants will either have just switched to HyQvia (within 6 weeks prior to screening), or plan to start HyQvia within 6 weeks after screening.

Study Length: We expect that your taking part in this research will last 12 months. Your study visits will coincide with your regular clinic visits.

Compensation: You will not be paid for being in this study.

Sponsor: Takeda Development Center Americas, Inc

Principal Investigator: Pritikanta Paul, MD

I'm Interested​

Multifocal Motor Neuropathy (MMN)

Brachial Neuritis (BN) 


Completed/Closed Studies